VizX Sells GeneSifter to UCLA, Temple University, Joslin Diabetes Center, and Others in Q4 | GenomeWeb

NEW YORK, Feb. 4 (GenomeWeb News) - Seattle-based VizX Labs said today that the University of California Los Angeles, Temple University, the Joslin Diabetes Center in Boston, Cardiff University, Wake Forest University, and Centre Hospitalier Universitaire de Montreal were among customers who purchased the company's flagship software product, GeneSifter, during the fourth quarter of 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.